Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Complete Title: A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in Subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Trial Phase: II
Investigator: Elizabeth Loggers

This is a study of genetically engineered ADP-A2M4 in HLA-A*02 subjects with metastatic or inoperable (advanced) Synovial Sarcoma or MRCLS who have received prior chemotherapy and whose tumor expresses the MAGE-A4 tumor antigen.

Keywords:
  • Liposarcoma, Myxoid/Round Cell
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

II
Elizabeth Loggers
RG1005467
NCT04044768
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in Subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Liposarcoma, Myxoid/Round Cell